Fragmin
Drug
Eisai Inc.
Total Payments
$15,817
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $15,817 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $15,817 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| FRG-IIS-021-09 | Eisai Inc. | $15,817 | 0 |
Top Doctors Receiving Payments for Fragmin
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Diego, CA | $15,817 | 1 |
Ad
Manufacturing Companies
- Eisai Inc. $15,817
Product Information
- Type Drug
- Total Payments $15,817
- Total Doctors 0
- Transactions 1
About Fragmin
Fragmin is a drug associated with $15,817 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Eisai Inc..
Payment data is available from 2017 to 2017. In 2017, $15,817 was paid across 1 transactions to 0 doctors.
The most common payment nature for Fragmin is "Unspecified" ($15,817, 100.0% of total).
Fragmin is associated with 1 research study, including "FRG-IIS-021-09" ($15,817).